Cargando…

miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation

In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Bulfoni, Michela, Pravisani, Riccardo, Dalla, Emiliano, Cesselli, Daniela, Hidaka, Masaaki, Di Loreto, Carla, Eguchi, Susumu, Baccarani, Umberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360178/
https://www.ncbi.nlm.nih.gov/pubmed/33818800
http://dx.doi.org/10.1002/jmv.26999
_version_ 1783737694641192960
author Bulfoni, Michela
Pravisani, Riccardo
Dalla, Emiliano
Cesselli, Daniela
Hidaka, Masaaki
Di Loreto, Carla
Eguchi, Susumu
Baccarani, Umberto
author_facet Bulfoni, Michela
Pravisani, Riccardo
Dalla, Emiliano
Cesselli, Daniela
Hidaka, Masaaki
Di Loreto, Carla
Eguchi, Susumu
Baccarani, Umberto
author_sort Bulfoni, Michela
collection PubMed
description In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have been tested only in explanted cirrhotic livers, when the liver damage has become chronic and irreversible. No data are available on the early phase of viral infection, such as early after liver transplantation (LT). In the present study, the expression of miR‐101, miR‐122, miR‐155, miR‐192, miR‐200c, miR‐338, and miR‐532 was determined by quantitative real‐time polymerase chain reaction in liver biopsies of HCV (n = 19) and HCV/HIV‐infected (n = 20) LT recipients, as well as in a control group (n = 18) of noninfected patients, transplanted for alcoholic cirrhosis. The timing of liver biopsy was 6 months post‐LT. None of the patients was treated with direct‐acting anti‐HCV drugs. All co‐infected recipients had suppressed HIV viral load. Grading and staging were assessed according to the Ishak Classification. HCV and HIV viral load were measured in the sera. miR‐101 (p = .03), miR‐122 (p = .012), and miR‐192 (p = .038) were significantly downregulated in HCV/HIV co‐infected and HCV mono‐infected recipients when compared with noninfected recipients, and such downregulation was more pronounced in co‐infected ones. Moreover, in co‐infected recipients but not in mono‐infected ones, miR‐101 inversely correlated with the peripheral HCV‐RNA levels (r = .41, p = .04) and miR‐122 inversely correlated with peripheral HCV‐RNA levels (r = .49, p = .03) and with the histological grading (r = .51, p = .02).  In conclusion, as early as 6 months after LT, the presence of HIV‐HCV co‐infection enhanced a significant downregulation of certain miRNAs that showed a direct correlation with HCV viral load and liver inflammation.
format Online
Article
Text
id pubmed-8360178
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83601782021-08-17 miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation Bulfoni, Michela Pravisani, Riccardo Dalla, Emiliano Cesselli, Daniela Hidaka, Masaaki Di Loreto, Carla Eguchi, Susumu Baccarani, Umberto J Med Virol Research Articles In hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co‐infected patients, HIV enhances HCV replication and liver damage. Several microRNAs (miRNAs), active in pro‐fibrotic and inflammatory pathways, have been implicated in the pathogenesis of this phenomenon. However, these miRNAs have been tested only in explanted cirrhotic livers, when the liver damage has become chronic and irreversible. No data are available on the early phase of viral infection, such as early after liver transplantation (LT). In the present study, the expression of miR‐101, miR‐122, miR‐155, miR‐192, miR‐200c, miR‐338, and miR‐532 was determined by quantitative real‐time polymerase chain reaction in liver biopsies of HCV (n = 19) and HCV/HIV‐infected (n = 20) LT recipients, as well as in a control group (n = 18) of noninfected patients, transplanted for alcoholic cirrhosis. The timing of liver biopsy was 6 months post‐LT. None of the patients was treated with direct‐acting anti‐HCV drugs. All co‐infected recipients had suppressed HIV viral load. Grading and staging were assessed according to the Ishak Classification. HCV and HIV viral load were measured in the sera. miR‐101 (p = .03), miR‐122 (p = .012), and miR‐192 (p = .038) were significantly downregulated in HCV/HIV co‐infected and HCV mono‐infected recipients when compared with noninfected recipients, and such downregulation was more pronounced in co‐infected ones. Moreover, in co‐infected recipients but not in mono‐infected ones, miR‐101 inversely correlated with the peripheral HCV‐RNA levels (r = .41, p = .04) and miR‐122 inversely correlated with peripheral HCV‐RNA levels (r = .49, p = .03) and with the histological grading (r = .51, p = .02).  In conclusion, as early as 6 months after LT, the presence of HIV‐HCV co‐infection enhanced a significant downregulation of certain miRNAs that showed a direct correlation with HCV viral load and liver inflammation. John Wiley and Sons Inc. 2021-05-04 2021-08 /pmc/articles/PMC8360178/ /pubmed/33818800 http://dx.doi.org/10.1002/jmv.26999 Text en © 2021 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Bulfoni, Michela
Pravisani, Riccardo
Dalla, Emiliano
Cesselli, Daniela
Hidaka, Masaaki
Di Loreto, Carla
Eguchi, Susumu
Baccarani, Umberto
miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title_full miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title_fullStr miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title_full_unstemmed miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title_short miRNA expression profiles in liver grafts of HCV and HIV/HCV‐infected recipients, 6 months after liver transplantation
title_sort mirna expression profiles in liver grafts of hcv and hiv/hcv‐infected recipients, 6 months after liver transplantation
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360178/
https://www.ncbi.nlm.nih.gov/pubmed/33818800
http://dx.doi.org/10.1002/jmv.26999
work_keys_str_mv AT bulfonimichela mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT pravisaniriccardo mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT dallaemiliano mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT cessellidaniela mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT hidakamasaaki mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT diloretocarla mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT eguchisusumu mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation
AT baccaraniumberto mirnaexpressionprofilesinlivergraftsofhcvandhivhcvinfectedrecipients6monthsafterlivertransplantation